Back to Journals » Vascular Health and Risk Management » Volume 8

New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders

Total article views   HTML views PDF downloads Totals
15,273 Dovepress* 10,720+ 3,122 13,842
PubMed Central* 4,553 2,439 6,992
Totals 15,273 5,561 20,834
*Since 25 January 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar